Marker Therapeutics Inc (MRKR)

[Phantom Lord]

I'm curious to know what your expectation of the company is. Obviously they need to be informing us of any material information in a timely manner. Other than that there is no timeline for any other updates. They can give them as they see fit and aren't going to share every step of the process with everyone.

They have elected to do two conference calls a year as that puts them in line with the rest of the industry. If I remember correctly we got three this year. One in the beginning of the year to review Q4 2018 results and where they disclosed that they would be presenting pancreatic data at an upcoming conference, the conference call when they presented that data, and this last conference call where they updated us on the PII ovarian trial and on the progress of the AML trial that was initially supposed to begin this year. I wasn't too thrilled with this last one but over the course of these three calls we were updated on everything that we knew was coming down the pipeline. I've posted a few times this year on upcoming events and what to expect heading into the end of the year. These were events detailed by the company that everyone knew would be addressed by the company. As of now they have all been addressed. My only concern is the FDA hold and when they knew about it. That was not clear enough and potentially should have been disclosed sooner. In any event it was disclosed so I don't know how upset I should be about it.

I'm not trying to argue with you so please don't take it that way. I just want to understand what everyone else's expectations are because as far as I'm concerned the company has shared everything they needed to this year as they knew about it in a relatively timely manner. If I'm completely missing something here please let me know.